Journal:Acta Cryst F:S2053230X25006181
From Proteopedia
(Difference between revisions)

Line 8: | Line 8: | ||
<scene name='10/1087727/021_fig_2a_png/5'>021_Fig_2a_png</scene> | <scene name='10/1087727/021_fig_2a_png/5'>021_Fig_2a_png</scene> | ||
- | Bacteria contain either one of two pathways to make menaquinone, the classical or futalosine pathways, and MenD catalyses the first irreversible step in the classical pathway. It takes two substrates, 2-oxoglutarate and isochorismate and converts them to SEPHCHC via a series of reactions involving covalent ThDP-bound intermediates. We have solved several structures of MenD from the listeria-causing pathogen Listeria monocytogenes. Analysis of the structures show a typical ThDP-dependent three-domain (PP, PYR, TH3 domain) fold similar to other MenD enzymes. Our first structure, captured in the ThDP cofactor-bound form has enabled us to visualise and understand how the co-factor binds. By comparing this structure to one without ThDP-bound (apo) in the protein databank we can see how the enzyme active site partially-closes around the co-factor. In our second structure we were able to capture reactivity within the crystal with an in-crystallo formed covalent ThDP-intermediate (Intermediate I) bound in the active site. Studying the shape and interactions of this intermediate helps us understand more about the chemistry of the enzyme. | + | Bacteria contain either one of two pathways to make menaquinone, the classical or futalosine pathways, and MenD catalyses the first irreversible step in the classical pathway. It takes two substrates, 2-oxoglutarate and isochorismate and converts them to SEPHCHC via a series of reactions involving covalent ThDP-bound intermediates. We have solved several structures of MenD from the listeria-causing pathogen Listeria monocytogenes. Analysis of the structures show a typical <scene name='10/1087727/021_fig_2a_png/5'>ThDP-dependent three-domain</scene> (PP, PYR, TH3 domain) fold similar to other MenD enzymes. Our first structure, captured in the ThDP cofactor-bound form has enabled us to visualise and understand how the co-factor binds. By comparing this structure to one without ThDP-bound (apo) in the protein databank we can see how the enzyme active site partially-closes around the co-factor. In our second structure we were able to capture reactivity within the crystal with an in-crystallo formed covalent ThDP-intermediate (Intermediate I) bound in the active site. Studying the shape and interactions of this intermediate helps us understand more about the chemistry of the enzyme. |
In additional studies we used our structural analysis combined with other methods (size-exclusion chromatography, mass photometry and small angle X-ray scattering analysis) to understand the oligomeric state of the enzyme. Showing that like other MenD’s, Listeria monocytogenes MenD has a homotetrameric quaternary structure. We also undertook enzyme kinetics to show the enzyme was active, and that there was weak inhibition of enzyme activity in the presence of 1,4- dihydroxy-2-naphthoic acid, a downstream metabolite in the menaquinone-biosynthesis pathway that has previously been shown to be a potent allosteric regulator of Mycobacterium tuberculosis MenD. | In additional studies we used our structural analysis combined with other methods (size-exclusion chromatography, mass photometry and small angle X-ray scattering analysis) to understand the oligomeric state of the enzyme. Showing that like other MenD’s, Listeria monocytogenes MenD has a homotetrameric quaternary structure. We also undertook enzyme kinetics to show the enzyme was active, and that there was weak inhibition of enzyme activity in the presence of 1,4- dihydroxy-2-naphthoic acid, a downstream metabolite in the menaquinone-biosynthesis pathway that has previously been shown to be a potent allosteric regulator of Mycobacterium tuberculosis MenD. |
Revision as of 20:29, 20 August 2025
|
This page complements a publication in scientific journals and is one of the Proteopedia's Interactive 3D Complement pages. For aditional details please see I3DC.